Breaking Research News from Breastcancer.org
Comments
-
Hormonal Birth Control Ups Breast Cancer Risk in Women With BRCA1 Mutations
Oct 23, 2024
The longer women with the mutation used hormonal contraception, the bigger the increase in risk. Read more…
0 -
Metastatic Recurrence Risk After Early-Stage Breast Cancer Drops
Nov 14, 2024
Treatments after surgery are more effective today and studies now include more women with lower-risk disease. Read more…
0 -
Adding Ibrance Stops Growth of Metastatic Triple-Positive Disease for More Than a Year
Dec 18, 2024
Progression-free survival was 15 months longer when Ibrance was added to standard treatment. Read more…
0 -
Dec 20, 2024
Combined with Verzenio, this new oral SERD may be a good option for advanced-stage breast cancer with an ESR1 mutation. Read more…
0 -
Active Monitoring May Be as Good as Surgery for Low-Risk DCIS
Dec 20, 2024
Two-year rates of invasive cancer were similar for women whether they had surgery or frequent mammograms, but more research is needed. Read more…
0 -
I thought this was an amazing breakthrough!
0 -
interesting @smn!
hank you for sharing!
0 -
WOW, get rid of the fat and the cancer all at once? Win win!
0 -
Breast Cancer Survivors With BRCA Mutation Have Higher Risk of Second Cancer
Jan 16, 2025
Risks were higher for a new cancer in the opposite breast, as well as ovarian, pancreatic, and prostate cancers. Read more…
0 -
After Early-Stage Breast Cancer, Risk of Metastatic Recurrence Higher for Younger People
Jan 16, 2025
Some breast cancers may be more likely to come back as metastatic disease five to 10 years after surgery in people ages 35 and younger. Read more…
0 -
One Chemo Medicine Before Surgery for Early-Stage HER2-Positive Breast Cancer May Be Better Than Two
Feb 5, 2025
Abraxane instead of Taxotere and carboplatin led to a better response and fewer serious side effects. Read more…
0 -
Should Doctors Regularly Screen for Breast Cancer Brain Metastases?
Mar 5, 2025
Research suggests current screening guidelines for brain mets need updating. Read more…
0 -
Racial Disparities Found in Same-Day Breast Diagnostic Services
Mar 31, 2025
The disparities may mean delays in diagnosis, which can lead to worse outcomes. Read more…
0 -
Camrelizumab Seems Promising As New Triple-Negative Breast Cancer Treatment
Apr 14, 2025
Adding the immunotherapy medicine camrelizumab to chemotherapy offered better outcomes than chemotherapy alone for TNBC. Read more…
0 -
Trodelvy and Keytruda as First Treatment for Metastatic TNBC: A New Standard of Care?
May 30, 2025
People lived longer without the cancer growing when they received Trodelvy and Keytruda compared to the current standard treatment. Read more…
0 -
New Hormonal Therapy Vepdegestrant Promising for Some Metastatic HR+ Breast Cancers
May 30, 2025
The new medicine offered more benefits than Faslodex. Read more…
0 -
May 31, 2025
After two years of follow-up, the new treatment improved survival and quality of life. Read more…
0 -
Enhertu Plus Perjeta: New First-Line Treatment for Metastatic HER2-Positive Breast Cancer?
Jun 1, 2025
The combination offered better outcomes than the THP chemo regimen. Read more…
0 -
COVID and Flu May Activate Breast Cancer Cells in Lungs
Aug 20, 2025
People with a history of breast cancer may want to consider COVID and flu vaccinations, according to the researchers. Read more…
0 -
Adding Tukysa to First Treatments Delays Growth of Metastatic HER2-Positive Breast Cancer
Dec 22, 2025
Delaying cancer growth may keep people out of the chemo chair. Read more…
0 -
Giredestrant Reduces Recurrence Risk More Than Tamoxifen, Aromatase Inhibitors
Dec 22, 2025
Results from the lidERA trial suggest that giredestrant could be a new standard of care for early-stage hormone receptor-positive breast cancer. Read more…
0 -
Proton Therapy Better Than Traditional Radiation for Leptomeningeal Disease
Jan 6, 2026
When treating breast cancer that’s spread to the cerebrospinal fluid, proton therapy controlled the cancer better than traditional X-ray radiation. Read more…
0
